HCP5 is a SMAD3-responsive long non-coding RNA that promotes lung adenocarcinoma metastasis via miR-203/SNAI axis

Ranran Wang, Li Fang, Xiaolu Ge, Lingna Chen, Ming Zhou, Yanhong Zhou, Wei Xiong, Yerong Hu, Xianming Tang, Guiyuan Li,

Theranostics · 2019 · 110 citations · 42 references

DOIFull text

Open access

Concepts

Abstract

: Our work demonstrates that the lncRNA HCP5 is transcriptionally regulated by SMAD3 and acts as a new regulator in the TGFβ/SMAD signaling pathway. Therefore, HCP5 can serve as a potential therapeutic target in LUAD.

References

42